Factors associated with survival in the National Registry of Veterans with ALS

References

• Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 208–12
   PubMed Web of Science ®Google Scholar
• del Aguila M, Longstreth W, McGuire V, Koepsell T, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003; 60: 813–9
   PubMed Web of Science ®Google Scholar
• Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology. 2005; 25: 114–9
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen A, Appel S. Amyotrophic lateral sclerosis: early predictors of prolonged survival. Journal of Neurology. 2006; 253: 1428–36
   PubMed Web of Science ®Google Scholar
• Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana M, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002; 59: 99–103
   PubMed Web of Science ®Google Scholar
• Chancellor A, Slattery J, Fraser H, Swingler R, Holloway S, Warlow C. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. Journal of Neurology. 1993; 240: 339–46
   PubMed Web of Science ®Google Scholar
• Turner M, Bakker M, Sham P, Shaw C, Leigh P, Al-Chalabi A. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002; 3: 15–21
   PubMed Web of Science ®Google Scholar
• Leveck D, Davies G. Rapid progression of amyotrophic lateral sclerosis presenting during pregnancy: a case report. Journal of Obstetrics and Gynaecology Canada. 2005; 27: 360–2
   PubMedGoogle Scholar
• Grohme K, Maravic M, Gasser T, Borasio G. A case of amyotrophic lateral sclerosis with a very slow progression over 44 years. Neuromuscular Disorders. 2001; 11: 414–6
   PubMed Web of Science ®Google Scholar
• Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle & Nerve. 1993; 16: 27–32
   PubMed Web of Science ®Google Scholar
• Haverkamp L, Appel V, Appel S. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995; 118: 707–19
   PubMed Web of Science ®Google Scholar
• Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka K. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle & Nerve. 2002; 25: 709–14
   PubMed Web of Science ®Google Scholar
• Mandrioli J, Faglioni P, Nichelli P, Sola P. Amyotrophic lateral sclerosis: prognostic indicators of survival. Amyotrophic Lateral Sclerosis. 2006; 7: 211–20
   PubMed Web of Science ®Google Scholar
• Stambler N, Charatan M, Cedarbaum J. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology. 1998; 50: 66–72
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen A, Appel S. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. Journal of Neurology, Neurosurgery and Psychiatry. 2006; 77: 390–2
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Levy G, Thompson J, Delbene M, Battista V, Gordon P, et al. The ALSFRS-R predicts survival time in an ALS clinic population. Neurology. 2005; 64: 38–43
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. Journal of Neurology, Neurosurgery and Psychiatry. 2003; 74: 1258–61
   PubMed Web of Science ®Google Scholar
• Chio A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. Journal of Neurology, Neurosurgery and Psychiatry. 2006; 77: 948–50
   PubMed Web of Science ®Google Scholar
• Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. The New England Journal of Medicine. 1994; 330: 585–91
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. An outcome study of riluzole in amyotrophic lateral sclerosis: a population-based study in Ireland, 1996–2000. Journal of Neurology. 2003; 250: 473–9
   PubMed Web of Science ®Google Scholar
• Haley R. Excess incidence of ALS in young Gulf War veterans. Neurology. 2003; 61: 750–6
   PubMed Web of Science ®Google Scholar
• Horner R, Kamins K, Feussner J, Grambow SC, Hoff-Lindquist J, Harati Y, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003; 61: 742–9
   PubMed Web of Science ®Google Scholar
• Weisskopf M, O'Reilly EJ, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, et al. Prospective study of military service and mortality from ALS. Neurology. 2005; 64: 32–7
   PubMed Web of Science ®Google Scholar
• Kasarkis E, Dominick K, Oddone E. The National Registry of Veterans with Amyotrophic Lateral Sclerosis: Department of Veterans Affairs Cooperative Studies Program (CSP) 500a. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5(Suppl 1)129–32
   PubMed Web of Science ®Google Scholar
• Allen KD, Kasarskis EJ, Bedlack RS, Rozear MP, Morgenlander JC, Sabet A, et al. The National Registry of Veterans with Amyotrophic Lateral Sclerosis. Neuroepidemiology. 2008; 30: 180–90
   PubMed Web of Science ®Google Scholar
• Brooks B. El Escorial World Federation of Neurology Criteria For the Diagnosis of Amyotrophic Lateral Sclerosis. J Neurol Sci. 1994; 124(Suppl)96–107
   PubMed Web of Science ®Google Scholar
• Cox D. Regression Models and Life Tables. J R Stat Soc B. 1972; 34: 187–220
   Google Scholar